Klinique Med (Thailand) Today
| KLINIQ Stock | 31.75 1.00 3.05% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Klinique Med is trading at 31.75 as of the 11th of December 2024, a 3.05 percent decrease since the beginning of the trading day. The stock's open price was 32.75. Klinique Med has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 22nd of December 2022 and ending today, the 11th of December 2024. Click here to learn more.
Moving against Klinique Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Klinique Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Klinique Med's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Klinique Med or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Director | Apiruj Thongwattana |
| Business Concentration | Personal Services, Consumer Cyclical (View all Sectors) |
The Klinique Med (KLINIQ) is traded on Thailand Exchange in Thailand and employs 2 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.81 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Klinique Med's market, we take the total number of its shares issued and multiply it by Klinique Med's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Klinique Med operates under Consumer Cyclical sector and is part of Personal Services industry. The entity has 220 M outstanding shares.
Check Klinique Med Probability Of Bankruptcy
Ownership AllocationKlinique Med maintains a total of 220 Million outstanding shares. The Klinique Med secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 73.66 % of The Klinique Med outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Klinique Ownership Details
Klinique Med Risk Profiles
Although Klinique Med's alpha and beta are two of the key measurements used to evaluate Klinique Med's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.48 | |||
| Standard Deviation | 1.97 | |||
| Variance | 3.87 | |||
| Risk Adjusted Performance | (0.04) |
Klinique Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Klinique Med without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
Other Information on Investing in Klinique Stock
Klinique Med financial ratios help investors to determine whether Klinique Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Klinique with respect to the benefits of owning Klinique Med security.